| Advances in metabolomics in critically ill patients with Sepsis and Septic Shock |
| Swarnima Pandey |
| University of Maryland, School of Pharmacy, Department of Pharmaceutical Sciences, Baltimore, MD, USA |
| Correspondence
Swarnima Pandey Tel: (667) 677-0652, Email: swarnima@gmail.com |
|
Received: March 5, 2024. Revised: May 30, 2024. Accepted: June 3, 2024. Published online: July 19, 2024. |
|
|
| ABSTRACT |
|
Sepsis accounts for high cases of morbidity and mortality in hospitalized patients. It has a very complex pathophysiology and swiftly progresses to a severe form of the disease, such as septic shock leading to organ dysfunction, organ failure, and death. Metabolomics has transformed sepsis's clinical and research topography with its application in prognosis, diagnosis, and risk assessment in patients with sepsis and septic shock. Metabolites in blood and urine are detected and analyzed, which helps in understanding the pathogenesis of the disease and aid in better disease management by identifying biomarkers early on. Metabolomics, sepsis and septic shock were the keywords were searched in PubMed and Scopus, from its inception to Dec 2023. This article provides information regarding metabolic profiling performed in sepsis and septic shock We demonstrated that metabolomics will change the world of sepsis by analyzing and detecting the diagnosis, prognosis, mortality, and treatment response biomarkers. |
| Keywords:
metabolomics, sepsis, septic shock, biomarkers, diagnosis, prognosis, monitor |
|
|
|
PDF Links
Full text via DOI
Download Citation 
